A new guidance from the US Department of Health & Human Services (HHS) paves the way for pharmacists nationwide to administer coronavirus disease 2019 (COVID-19) tests.
Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), joined Drug Topics® to discuss their recent survey that pinpointed where pharmacists are feeling most unprotected during the pandemic.
Approximately 20% to 30% of men with metastatic castration-resistant prostate cancer have HRR gene mutation.
A new review in JAMA Pediatrics looks at the current status of PrEP uptake among adolescents aged 13 to 19 years who are at risk for HIV.
Monitoring and controlling heart disease may be crucial in supporting cognitive health later in life.
Atezolizumab demonstrated a significant overall survival benefit in individuals with high PD-L1 expression compared with chemotherapy.
The US Department of Health & Human Services has left it up to state health departments to decide how to distribute remdesivir to hospitals.
Officials with the FDA have granted breakthrough therapy designation to trastuzumab deruxtecan (Enhertu, AstraZeneca and Daiichi Sankyo) for the treatment of HER2-mutant metastatic non-small cell lung cancer (NSCLC).
Community pharmacies are ideally positioned to support reopening efforts and recovery plans amid the coronavirus disease 2019 pandemic.
Rucaparib is the first PARP inhibitor that has been approved in a prostate cancer setting.